Dynamic Technology Lab Private Ltd decreased its stake in shares of Cigna Corporation (NYSE:CI) by 71.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,950 shares of the health services provider’s stock after selling 4,802 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Cigna were worth $365,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Rothschild Asset Management Inc. lifted its holdings in Cigna by 1.9% in the second quarter. Rothschild Asset Management Inc. now owns 4,289 shares of the health services provider’s stock worth $718,000 after acquiring an additional 79 shares during the last quarter. CIBC Asset Management Inc lifted its holdings in Cigna by 0.4% in the second quarter. CIBC Asset Management Inc now owns 25,297 shares of the health services provider’s stock worth $4,234,000 after acquiring an additional 105 shares during the last quarter. Lockheed Martin Investment Management Co. bought a new position in Cigna in the second quarter worth about $670,000. Daiwa Securities Group Inc. lifted its holdings in Cigna by 22.8% in the second quarter. Daiwa Securities Group Inc. now owns 8,900 shares of the health services provider’s stock worth $1,490,000 after acquiring an additional 1,650 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new position in Cigna in the second quarter worth about $211,000. 87.84% of the stock is currently owned by institutional investors and hedge funds.

In other Cigna news, EVP Alan Muney sold 15,345 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The shares were sold at an average price of $200.80, for a total value of $3,081,276.00. Following the sale, the executive vice president now owns 28,457 shares in the company, valued at $5,714,165.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director William D. Zollars sold 1,232 shares of the firm’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders sold 36,203 shares of company stock worth $7,211,251 in the last 90 days. 1.30% of the stock is owned by company insiders.

Shares of Cigna Corporation (NYSE CI) traded down $3.32 during trading hours on Friday, hitting $208.41. 1,442,418 shares of the company’s stock traded hands, compared to its average volume of 1,208,917. Cigna Corporation has a 12 month low of $131.03 and a 12 month high of $212.46. The firm has a market capitalization of $52,179.78, a price-to-earnings ratio of 20.39, a P/E/G ratio of 1.62 and a beta of 0.50. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37.

Cigna (NYSE:CI) last announced its quarterly earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the consensus estimate of $2.36 by $0.47. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The company had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. During the same quarter last year, the business earned $1.94 earnings per share. Cigna’s revenue was up 5.1% compared to the same quarter last year. sell-side analysts anticipate that Cigna Corporation will post 10.34 EPS for the current fiscal year.

A number of brokerages have issued reports on CI. Zacks Investment Research cut shares of Cigna from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Citigroup raised their target price on shares of Cigna from $198.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Morgan Stanley raised their target price on shares of Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a report on Friday, November 3rd. Jefferies Group raised their target price on shares of Cigna from $221.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $220.00 target price (up previously from $185.00) on shares of Cigna in a report on Friday, November 3rd. Three equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $201.50.

TRADEMARK VIOLATION WARNING: “Cigna Corporation (CI) Shares Sold by Dynamic Technology Lab Private Ltd” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/12/02/cigna-corporation-ci-shares-sold-by-dynamic-technology-lab-private-ltd.html.

Cigna Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Stock Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related stocks with our FREE daily email newsletter.